USA flag logo/image

An Official Website of the United States Government

Point Source Ozonation to Minimize Antibiotic Resistance

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
76231
Program Year/Program:
2005 / STTR
Agency Tracking Number:
ES014137
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
BIODETECTION INSTRUMENTS, LLC
535 W Research Blvd., Suite 135, M/S 300 FAYETTEVILLE, AR 72701-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2005
Title: Point Source Ozonation to Minimize Antibiotic Resistance
Agency: HHS
Contract: 1R41ES014137-01
Award Amount: $100,000.00
 

Abstract:

DESCRIPTION (provided by applicant): BluelnGreen, LLC proposes to develop an effective, versatile and cost efficient device for the application of ozone micro-bubbles to the effluent of critical point sources of medical wastewater (hospitals, large clinics and pharmaceutical manufacturing plants) to reduce the overall amount of both antibiotic residuals and resistant pathogens that are released to the environment. By directly treating the wastewater effluent of medical point sources, the concentrations of both antibiotic residuals and bacteria can be greatly reduced before being mixed with general wastewater at a centralized treatment facility, thereby lowering the risk of developing antibiotic resistance in the wastewater treatment process and minimizing the volume of wastewater that must be treated. We estimate that the widespread use of this device will significantly contribute to the reduction of antibiotic resistant pathogens in the human ecosystem and help maintain the efficacy of medically important antibiotics. In Phase I, BluelnGreen will demonstrate that the proposed device (the ozone micro-bubbler) can more effectively and efficiently reduce the concentration of two representative antibiotic residuals (ciprofloxacin and levofloxacin) and representative pathogens (total coliform, fecal coliform, and E. coli) in a model hospital wastewater effluent pipe when compared to existing decontamination technology (chlorination and macro-bubble ozonation). We will also assess the formation of byproducts formed during oxidation of the antibiotics via ozonation and chlorination. It is our projection that the proposed technology of micro-bubble ozonation will excel over existing technologies in terms of practicality, operating cost estimate, and reduction of antibiotic and bacterial load.

Principal Investigator:

Clay Thompson
4795712592
CTHOMPSON@VIRTUAL-INCUBATION.COM

Business Contact:


4795712592
Small Business Information at Submission:

Blueingreen, LLC
Blueingreen, Llc 535 Research Blvd, Ste 135, Ms 800 Fayetteville, AR 72701

EIN/Tax ID: 134281490
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
GEORGIA INSITUTE OF TECHNOLOGY
GEORGIA INSTITUTE OF TECHNOLOGY
505 10TH ST NW
ATLANTA, GA 30332
RI Type: Nonprofit college or university